Recruiting
Chronic lymphocytic leukaemia+1
RecruitingA Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded
Registered drugNo placebo
A Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded
Registered drugNo placebo
- Disease:Chronic lymphocytic leukaemiaB-cell small lymphocytic lymphoma
- Substances:BirelentinibIdelalisib+2
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Birelentinib

